← Open Payments lookup

CAROLINE LUKANO: Open Payments

NPI 1023498466 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$572 in 29 payments from 12 companies in 2025. Trend: 2023 $1,620 · 2024 $1,074 · 2025 $572

Food & beverage: $572
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$142
E.R. Squibb & Sons, L.L.C.4$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$71
Vanda Pharmaceuticals Inc.3$60
Otsuka America Pharmaceutical, Inc.3$54
Janssen Pharmaceuticals, Inc3$52
Alkermes, Inc.2$36
Lundbeck LLC1$17
Noven Therapeutics, LLC1$17
Luye Pharma (USA) Ltd.1$16

Products named: INGREZZA, COBENFY, CAPLYTA, FANAPT, ABILIFY MAINTENA, ARISTADA, SPRAVATO, INVEGA SUSTENNA.

Industry payments across GA — which companies pay providers there.